KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Inventory (2016 - 2025)

Idexx Laboratories has reported Inventory over the past 17 years, most recently at $377.8 million for Q4 2025.

  • Quarterly results put Inventory at $377.8 million for Q4 2025, down 1.08% from a year ago — trailing twelve months through Dec 2025 was $377.8 million (down 1.08% YoY), and the annual figure for FY2025 was $377.8 million, down 1.08%.
  • Inventory for Q4 2025 was $377.8 million at Idexx Laboratories, down from $391.6 million in the prior quarter.
  • Over the last five years, Inventory for IDXX hit a ceiling of $396.0 million in Q1 2025 and a floor of $225.6 million in Q1 2021.
  • Median Inventory over the past 5 years was $380.1 million (2023), compared with a mean of $350.6 million.
  • Biggest five-year swings in Inventory: surged 37.77% in 2022 and later decreased 3.84% in 2024.
  • Idexx Laboratories' Inventory stood at $269.0 million in 2021, then skyrocketed by 36.72% to $367.8 million in 2022, then rose by 3.39% to $380.3 million in 2023, then increased by 0.42% to $381.9 million in 2024, then decreased by 1.08% to $377.8 million in 2025.
  • The last three reported values for Inventory were $377.8 million (Q4 2025), $391.6 million (Q3 2025), and $392.6 million (Q2 2025) per Business Quant data.